Table 2. Spearman correlations between proteasome and ubiquitin with various clinical and laboratory data.

AML						MDS					ALL
	Protea somes	Ubiqui tin	Ch-L/P	Tr-L/P	Cas-L/P	Proteas omes	Ubiq uitin	Ch- L/P	Tr- L/P	Cas- L/P	Protea somes	Ubiq uitin	Ch- L/P	Tr- L/P	Cas- L/P
Age	−0.03	−0.07	−0.04	0.02	−0.03	−0.11	−0.16	0.00	0.02	0.07	−0.08	−0.27	0.19	−0.09	0.17
B2M	0.31	0.23	−0.13	−0.28	−0.03	0.32	−0.07	−0.06	−0.23	−0.10	0.54	0.37	−0.29	−0.45	−0.31
WBC	0.36	0.46	−0.18	−0.22	−0.02	0.40	0.15	−0.32	−0.35	−0.29	0.46	0.41	−0.61	−0.21	−0.55
Blood blasts (%)	0.30	0.25	−0.16	−0.19	0.01	0.38	−0.07	−0.39	−0.41	−0.35	0.62	0.48	−0.57	−0.47	−0.68
Platelets	0.05	0.07	−0.16	0.10	−0.09	−0.02	0.09	0.01	0.14	−0.14	−0.23	−0.28	−0.02	0.29	0.24
HGB	−0.06	0.08	−0.05	0.07	−0.10	−0.32	−0.22	−0.01	0.15	0.01	−0.22	−0.19	0.00	0.35	0.08
Marrow Blasts (%)	0.07	0.26	0.01	−0.06	0.05	0.51	0.20	−0.12	−0.43	−0.22	−0.11	0.03	−0.09	0.00	0.19
BUN	0.06	0.09	0.03	−0.14	0.05	−0.09	−0.22	−0.05	−0.04	−0.05	−0.11	−0.03	0.09	−0.05	−0.07
Creatinine	0.10	0.06	−0.12	−0.21	0.01	−0.08	0.00	−0.10	−0.17	−0.20	−0.10	−0.07	0.15	−0.04	−0.10
LDH	0.56	0.32	−0.17	−0.45	−0.04	0.31	0.11	−0.01	−0.13	−0.15	0.74	0.69	−0.52	−0.58	−0.57
Ch-L	0.80	0.37	0.05	−0.55	0.06	0.76	0.64	0.12	−0.54	−0.13	0.47	0.34	0.12	−0.38	−0.02
Tr-L	0.20	0.15	−0.07	0.47	−0.05	−0.20	0.06	0.36	0.71	0.46	0.01	0.15	0.02	0.54	−0.05
Cas-L	0.80	0.45	−0.07	−0.56	0.19	0.73	0.54	0.06	−0.39	−0.03	0.44	0.25	−0.07	−0.44	0.22
Proteasome		0.42	−0.49	−0.72	−0.37		0.43	−0.48	−0.77	−0.64		0.77	−0.75	−0.80	−0.74
Ubiquitin	0.42		−0.16	−0.29	0.00	0.43		0.23	−0.20	−0.07	0.77		−0.50	−0.47	−0.65
Ch-L/P	−0.49	−0.16		0.39	0.75	−0.48	0.23		0.56	0.83	−0.75	−0.50		0.61	0.75
Tr-L/P	−0.72	−0.29	0.39		0.32	−0.77	−0.20	0.56		0.72	−0.80	−0.47	0.61		0.52
Cas-L/P	−0.37	0.00	0.75	0.32		−0.64	−0.07	0.83	0.72		−0.74	−0.65	0.75	0.52